{"id":228700,"date":"2026-09-03T11:54:29","date_gmt":"2026-09-03T06:24:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=228700"},"modified":"2026-09-03T11:54:30","modified_gmt":"2026-09-03T06:24:30","slug":"jb-chemicals-pharmaceuticals-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jb-chemicals-pharmaceuticals-share-price-buy-hold-or-sell\/","title":{"rendered":"JB Chemicals and Pharmaceuticals: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"
<\/div>\n

JB Chemicals share price Rs 2,408.90 (NSE), near its 52-week high. 52-week range Rs 1,638.50 to Rs 2,525.50. FY26 profit up 7.6% YoY to Rs 709.47 crore.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

JB Chemicals and Pharmaceuticals share price is trading around Rs 2,409, close to its 52-week high of Rs 2,525.50 and well above its 52-week low of Rs 1,638.50. For the full year FY26, revenue grew 6.4 percent year on year to Rs 4,207.94 crore, with net profit up 7.6 percent to Rs 709.47 crore; specific Q1 FY27 figures were not independently confirmed across sources at the time of writing, so the most recently verified quarter is Q4 FY26. The stock trades at 54.6 times earnings, a premium to the pharmaceutical sector average near 38 times. Investors who value the company’s debt free balance sheet and steady growth may see the current level as reasonable, while others may want confirmed Q1 FY27 numbers before adding fresh exposure.<\/p>\n<\/div>\n

JB Chemicals and Pharmaceuticals share price is trading close to its 52-week high of Rs 2,525.50, with JB Chemicals share price near Rs 2,409 on the NSE, well above its 52-week low of Rs 1,638.50. With the stock near its highs following steady full-year growth, investors are asking whether this branded pharmaceutical company is a stock to buy right now, a hold, or a sell given the premium valuation.<\/p>\n

This JB Chemicals stock analysis walks through the most recently confirmed results, valuation against the pharmaceutical sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings. Specific Q1 FY27 quarterly figures were not consistently confirmed across sources at the time of writing, so this article references the most recently verified full-year and quarterly data.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n